Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	sweet taste receptor activity	TAS1R3 TAS1R2	2.05e-05	2	91	2	GO:0033041
GeneOntologyMolecularFunction	microfilament motor activity	MYH6 MYH7 MYH7B MYO19	2.65e-05	38	91	4	GO:0000146
GeneOntologyMolecularFunction	ceramide phosphoethanolamine synthase activity	SGMS1 SAMD8	6.14e-05	3	91	2	GO:0002950
GeneOntologyMolecularFunction	ceramide cholinephosphotransferase activity	SGMS1 SAMD8	6.14e-05	3	91	2	GO:0047493
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGL PYGM	6.14e-05	3	91	2	GO:0008184
GeneOntologyMolecularFunction	sphingomyelin synthase activity	SGMS1 SAMD8	6.14e-05	3	91	2	GO:0033188
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGL PYGM	2.04e-04	5	91	2	GO:0004645
GeneOntologyMolecularFunction	protein kinase activity	MST1R FRK PLK2 TBK1 DAPK1 PEAK1 MELK CDC42BPB MMD ALPK2	4.02e-04	600	91	10	GO:0004672
GeneOntologyMolecularFunction	kinase activity	MST1R FRK PLK2 SGMS1 TBK1 DAPK1 PEAK1 MELK CDC42BPB MMD ALPK2	6.98e-04	764	91	11	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	MST1R FRK PLK2 SGMS1 SAMD8 TBK1 DAPK1 PEAK1 MELK CDC42BPB MMD ALPK2	1.11e-03	938	91	12	GO:0016772
GeneOntologyMolecularFunction	non-membrane spanning protein tyrosine kinase activity	FRK PEAK1 MELK	1.21e-03	46	91	3	GO:0004715
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	MST1R FRK PLK2 TBK1 DAPK1 PEAK1 MELK CDC42BPB MMD ALPK2	1.44e-03	709	91	10	GO:0016773
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of sweet taste	TAS1R3 TAS1R2	1.88e-05	2	90	2	GO:0001582
GeneOntologyCellularComponent	sweet taste receptor complex	TAS1R3 TAS1R2	1.92e-05	2	92	2	GO:1903767
GeneOntologyCellularComponent	taste receptor complex	TAS1R3 TAS1R2	1.92e-05	2	92	2	GO:1903768
GeneOntologyCellularComponent	actin cytoskeleton	MST1R MYADM MYH6 MYH7 MYH7B MYO19 ANKRD26 DAPK1 ACTL9 PEAK1 CDC42BPB	4.51e-05	576	92	11	GO:0015629
GeneOntologyCellularComponent	myosin complex	MYH6 MYH7 MYH7B MYO19	1.33e-04	59	92	4	GO:0016459
GeneOntologyCellularComponent	myosin filament	MYH6 MYH7 MYH7B	1.77e-04	25	92	3	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH6 MYH7 MYH7B	2.50e-04	28	92	3	GO:0016460
GeneOntologyCellularComponent	laminin complex	NTN4 LAMA3	8.43e-04	10	92	2	GO:0043256
GeneOntologyCellularComponent	transferase complex	CCNJL UBR2 SPTLC3 ZZZ3 ANKRD9 TBK1 DAPK1 E2F6 WDFY3 ACTL9 CCNJ CUL7	1.04e-03	963	92	12	GO:1990234
Domain	Myosin_head_motor_dom	MYH6 MYH7 MYO15B MYH7B MYO19	1.03e-06	38	90	5	IPR001609
Domain	MYOSIN_MOTOR	MYH6 MYH7 MYO15B MYH7B MYO19	1.03e-06	38	90	5	PS51456
Domain	Myosin_head	MYH6 MYH7 MYO15B MYH7B MYO19	1.03e-06	38	90	5	PF00063
Domain	MYSc	MYH6 MYH7 MYO15B MYH7B MYO19	1.03e-06	38	90	5	SM00242
Domain	Laminin_G	FAT2 FAT3 LAMA3 COL14A1 USH2A	8.70e-06	58	90	5	IPR001791
Domain	LAM_G_DOMAIN	FAT2 FAT3 LAMA3 USH2A	3.28e-05	38	90	4	PS50025
Domain	Laminin_G_2	FAT2 FAT3 LAMA3 USH2A	4.04e-05	40	90	4	PF02210
Domain	Myosin_N	MYH6 MYH7 MYH7B	4.72e-05	15	90	3	PF02736
Domain	Myosin_N	MYH6 MYH7 MYH7B	4.72e-05	15	90	3	IPR004009
Domain	Laminin_N	NTN4 LAMA3 USH2A	5.79e-05	16	90	3	IPR008211
Domain	LAMININ_NTER	NTN4 LAMA3 USH2A	5.79e-05	16	90	3	PS51117
Domain	Laminin_N	NTN4 LAMA3 USH2A	5.79e-05	16	90	3	PF00055
Domain	LamNT	NTN4 LAMA3 USH2A	5.79e-05	16	90	3	SM00136
Domain	LamG	FAT2 FAT3 LAMA3 USH2A	5.91e-05	44	90	4	SM00282
Domain	PHOSPHORYLASE	PYGL PYGM	6.87e-05	3	90	2	PS00102
Domain	Sphingomyelin_synth-like_dom	SGMS1 SAMD8	6.87e-05	3	90	2	IPR025749
Domain	Phosphorylase	PYGL PYGM	6.87e-05	3	90	2	PF00343
Domain	Glycg_phsphrylas	PYGL PYGM	6.87e-05	3	90	2	IPR011833
Domain	PAP2_C	SGMS1 SAMD8	6.87e-05	3	90	2	PF14360
Domain	Glyco_trans_35	PYGL PYGM	6.87e-05	3	90	2	IPR000811
Domain	IQ_motif_EF-hand-BS	MYH6 MYH7 MYO15B MYH7B MYO19	7.39e-05	90	90	5	IPR000048
Domain	Myosin_tail_1	MYH6 MYH7 MYH7B	8.38e-05	18	90	3	PF01576
Domain	Myosin_tail	MYH6 MYH7 MYH7B	8.38e-05	18	90	3	IPR002928
Domain	IQ	MYH6 MYH7 MYO15B MYH7B MYO19	8.64e-05	93	90	5	PS50096
Domain	-	FAT2 FAT3 LAMA3 WDFY3 USH2A	9.57e-05	95	90	5	2.60.120.200
Domain	Myosin-like_IQ_dom	MYH6 MYH7 MYH7B	9.92e-05	19	90	3	IPR027401
Domain	-	MYH6 MYH7 MYH7B	9.92e-05	19	90	3	4.10.270.10
Domain	EGF_1	NTN4 FAT2 FAT3 LAMA3 ASTN2 VWA2 USH2A	2.32e-04	255	90	7	PS00022
Domain	Kinase-like_dom	MST1R FRK PLK2 TBK1 WDR81 DAPK1 PEAK1 MELK CDC42BPB ALPK2	2.78e-04	542	90	10	IPR011009
Domain	EGF_LAM_2	NTN4 LAMA3 USH2A	4.00e-04	30	90	3	PS50027
Domain	EGF_LAM_1	NTN4 LAMA3 USH2A	4.00e-04	30	90	3	PS01248
Domain	IQ	MYH6 MYH7 MYH7B MYO19	6.32e-04	81	90	4	SM00015
Domain	Laminin_EGF	NTN4 LAMA3 USH2A	6.33e-04	35	90	3	PF00053
Domain	EGF_Lam	NTN4 LAMA3 USH2A	6.33e-04	35	90	3	SM00180
Domain	ConA-like_dom	FAT2 FAT3 LAMA3 COL14A1 WDFY3 USH2A	6.66e-04	219	90	6	IPR013320
Domain	P-loop_NTPase	MYH6 MYH7 RAB33A MYO15B TDRD9 ABCA12 MYH7B VPS4A MYO19 HELZ2 DAPK1 RAB33B	7.48e-04	848	90	12	IPR027417
Domain	Laminin_EGF	NTN4 LAMA3 USH2A	8.08e-04	38	90	3	IPR002049
Domain	BEACH_dom	WDR81 WDFY3	8.09e-04	9	90	2	IPR000409
Domain	BEACH	WDR81 WDFY3	8.09e-04	9	90	2	PS50197
Domain	Beach	WDR81 WDFY3	8.09e-04	9	90	2	PF02138
Domain	-	WDR81 WDFY3	8.09e-04	9	90	2	1.10.1540.10
Domain	Beach	WDR81 WDFY3	8.09e-04	9	90	2	SM01026
Domain	AdipoR/HlyIII-related	ADIPOR1 MMD	1.23e-03	11	90	2	IPR004254
Domain	HlyIII	ADIPOR1 MMD	1.23e-03	11	90	2	PF03006
Domain	PROTEIN_KINASE_ATP	MST1R FRK PLK2 TBK1 DAPK1 PEAK1 MELK CDC42BPB	1.67e-03	459	90	8	PS00107
Domain	NCD3G	TAS1R3 TAS1R2	1.73e-03	13	90	2	PF07562
Domain	GPCR_3_9-Cys_dom	TAS1R3 TAS1R2	1.73e-03	13	90	2	IPR011500
Domain	GPCR_3_CS	TAS1R3 TAS1R2	2.01e-03	14	90	2	IPR017979
Domain	Protein_kinase_ATP_BS	MST1R FRK PLK2 TBK1 DAPK1 MELK CDC42BPB	2.37e-03	379	90	7	IPR017441
Domain	Prot_kinase_dom	MST1R FRK PLK2 TBK1 DAPK1 PEAK1 MELK CDC42BPB	2.47e-03	489	90	8	IPR000719
Domain	PROTEIN_KINASE_DOM	MST1R FRK PLK2 TBK1 DAPK1 PEAK1 MELK CDC42BPB	2.60e-03	493	90	8	PS50011
Domain	Cyclin_C	CCNJL CCNJ	2.98e-03	17	90	2	PF02984
Domain	Cyclin_C-dom	CCNJL CCNJ	2.98e-03	17	90	2	IPR004367
Domain	Cyclin_C	CCNJL CCNJ	2.98e-03	17	90	2	SM01332
Domain	GPCR_3	TAS1R3 TAS1R2	4.54e-03	21	90	2	IPR000337
Domain	7tm_3	TAS1R3 TAS1R2	4.98e-03	22	90	2	PF00003
Domain	G_PROTEIN_RECEP_F3_2	TAS1R3 TAS1R2	4.98e-03	22	90	2	PS00980
Domain	G_PROTEIN_RECEP_F3_3	TAS1R3 TAS1R2	4.98e-03	22	90	2	PS00981
Domain	G_PROTEIN_RECEP_F3_1	TAS1R3 TAS1R2	4.98e-03	22	90	2	PS00979
Domain	G_PROTEIN_RECEP_F3_4	TAS1R3 TAS1R2	4.98e-03	22	90	2	PS50259
Domain	GPCR_3_C	TAS1R3 TAS1R2	4.98e-03	22	90	2	IPR017978
Domain	HR1_rho-bd	RHPN1 TBC1D4	6.41e-03	25	90	2	IPR011072
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK2 FAT2 MYO15B HELZ2 ANKRD26 ASTN2 PEAK1 CUL7 CDC42BPB KLHL18 ARHGEF15	8.90e-08	493	93	11	15368895
Pubmed	The thyroid hormone receptor alpha1 protein is expressed in embryonic postmitotic neurons and persists in most adult neurons.	MYH6 MYH7 THRA	3.01e-06	11	93	3	20739404
Pubmed	Association of sweet taste receptor gene polymorphisms with dental caries experience in school children.	TAS1R3 TAS1R2	7.07e-06	2	93	2	25924601
Pubmed	Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.	MYH6 MYH7	7.07e-06	2	93	2	21526716
Pubmed	Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.	MYH6 MYH7	7.07e-06	2	93	2	18480046
Pubmed	The mechanism of interaction of sweet proteins with the T1R2-T1R3 receptor: evidence from the solution structure of G16A-MNEI.	TAS1R3 TAS1R2	7.07e-06	2	93	2	12706725
Pubmed	Sweet taste receptor deficient mice have decreased adiposity and increased bone mass.	TAS1R3 TAS1R2	7.07e-06	2	93	2	24466105
Pubmed	Interactions between the human sweet-sensing T1R2-T1R3 receptor and sweeteners detected by saturation transfer difference NMR spectroscopy.	TAS1R3 TAS1R2	7.07e-06	2	93	2	19664591
Pubmed	Murine pulmonary myocardium: developmental analysis of cardiac gene expression.	MYH6 MYH7	7.07e-06	2	93	2	7919499
Pubmed	T1R2+T1R3-independent chemosensory inputs contributing to behavioral discrimination of sugars in mice.	TAS1R3 TAS1R2	7.07e-06	2	93	2	30624973
Pubmed	The importance of the presence of a 5'-ribonucleotide and the contribution of the T1R1 + T1R3 heterodimer and an additional low-affinity receptor in the taste detection of L-glutamate as assessed psychophysically.	TAS1R3 TAS1R2	7.07e-06	2	93	2	25253867
Pubmed	Structural architecture of a dimeric class C GPCR based on co-trafficking of sweet taste receptor subunits.	TAS1R3 TAS1R2	7.07e-06	2	93	2	30723160
Pubmed	T1R2 and T1R3 subunits are individually unnecessary for normal affective licking responses to Polycose: implications for saccharide taste receptors in mice.	TAS1R3 TAS1R2	7.07e-06	2	93	2	19158407
Pubmed	Long-Read Sequence Confirmed a Large Deletion Including MYH6 and MYH7 in an Infant of Atrial Septal Defect and Atrial Arrhythmias.	MYH6 MYH7	7.07e-06	2	93	2	34384224
Pubmed	Disruption of the sugar-sensing receptor T1R2 attenuates metabolic derangements associated with diet-induced obesity.	TAS1R3 TAS1R2	7.07e-06	2	93	2	26884387
Pubmed	Characterization of human cardiac myosin heavy chain genes.	MYH6 MYH7	7.07e-06	2	93	2	2726733
Pubmed	Distinct human and mouse membrane trafficking systems for sweet taste receptors T1r2 and T1r3.	TAS1R3 TAS1R2	7.07e-06	2	93	2	25029362
Pubmed	Orosensory detection of sucrose, maltose, and glucose is severely impaired in mice lacking T1R2 or T1R3, but Polycose sensitivity remains relatively normal.	TAS1R3 TAS1R2	7.07e-06	2	93	2	22621968
Pubmed	Micro and macro models of the sweet receptor.	TAS1R3 TAS1R2	7.07e-06	2	93	2	15738209
Pubmed	Sucralose regulates postprandial blood glucose in mice through intestinal sweet taste receptors Tas1r2/Tas1r3.	TAS1R3 TAS1R2	7.07e-06	2	93	2	37938171
Pubmed	Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13.	MYH6 MYH7	7.07e-06	2	93	2	2494889
Pubmed	Human cardiac myosin heavy chain genes and their linkage in the genome.	MYH6 MYH7	7.07e-06	2	93	2	3037493
Pubmed	β-myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes.	MYH6 MYH7	7.07e-06	2	93	2	21778428
Pubmed	Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6).	MYH6 MYH7	7.07e-06	2	93	2	8307559
Pubmed	Behavioral evidence for a glucose polymer taste receptor that is independent of the T1R2+3 heterodimer in a mouse model.	TAS1R3 TAS1R2	7.07e-06	2	93	2	21940444
Pubmed	Salivary leptin and TAS1R2/TAS1R3 polymorphisms are related to sweet taste sensitivity and carbohydrate intake from a buffet meal in healthy young adults.	TAS1R3 TAS1R2	7.07e-06	2	93	2	29110749
Pubmed	Binding Hotspot and Activation Mechanism of Maltitol and Lactitol toward the Human Sweet Taste Receptor.	TAS1R3 TAS1R2	7.07e-06	2	93	2	32551626
Pubmed	A novel Rab GTPase, Rab33B, is ubiquitously expressed and localized to the medial Golgi cisternae.	RAB33A RAB33B	7.07e-06	2	93	2	9512502
Pubmed	The anatomy of mammalian sweet taste receptors.	TAS1R3 TAS1R2	7.07e-06	2	93	2	27936499
Pubmed	Distinct contributions of T1R2 and T1R3 taste receptor subunits to the detection of sweet stimuli.	TAS1R3 TAS1R2	7.07e-06	2	93	2	16271873
Pubmed	Thyroid hormone receptor alpha 1 regulates expression of the Na+/H+ exchanger (NHE1).	SLC9A1 THRA	7.07e-06	2	93	2	12039959
Pubmed	Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.	MYH6 MYH7	7.07e-06	2	93	2	2969919
Pubmed	All-atom molecular dynamics simulations of actin-myosin interactions: a comparative study of cardiac α myosin, β myosin, and fast skeletal muscle myosin.	MYH6 MYH7	7.07e-06	2	93	2	24224850
Pubmed	Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart.	MYH6 MYH7	7.07e-06	2	93	2	17575272
Pubmed	Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium.	MYH6 MYH7	7.07e-06	2	93	2	16088376
Pubmed	Key amino acid residues involved in multi-point binding interactions between brazzein, a sweet protein, and the T1R2-T1R3 human sweet receptor.	TAS1R3 TAS1R2	7.07e-06	2	93	2	20302879
Pubmed	Complete sequence of human cardiac alpha-myosin heavy chain gene and amino acid comparison to other myosins based on structural and functional differences.	MYH6 MYH7	7.07e-06	2	93	2	1776652
Pubmed	Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.	MYH6 MYH7	7.07e-06	2	93	2	9884344
Pubmed	Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes.	MYH6 MYH7	7.07e-06	2	93	2	12750067
Pubmed	Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER.	SGMS1 SAMD8	7.07e-06	2	93	2	19506037
Pubmed	The binding site for neohesperidin dihydrochalcone at the human sweet taste receptor.	TAS1R3 TAS1R2	7.07e-06	2	93	2	17935609
Pubmed	Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.	MYH6 MYH7	7.07e-06	2	93	2	9541509
Pubmed	A TAS1R receptor-based explanation of sweet 'water-taste'.	TAS1R3 TAS1R2	7.07e-06	2	93	2	16633339
Pubmed	Detection of maltodextrin and its discrimination from sucrose are independent of the T1R2 + T1R3 heterodimer.	TAS1R3 TAS1R2	7.07e-06	2	93	2	28768658
Pubmed	Modeling and Structural Characterization of the Sweet Taste Receptor Heterodimer.	TAS1R3 TAS1R2	7.07e-06	2	93	2	31553164
Pubmed	Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.	MYH6 MYH7	7.07e-06	2	93	2	23580644
Pubmed	Sugar-induced cephalic-phase insulin release is mediated by a T1r2+T1r3-independent taste transduction pathway in mice.	TAS1R3 TAS1R2	7.07e-06	2	93	2	26157055
Pubmed	β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.	MYH6 MYH7	7.07e-06	2	93	2	24829265
Pubmed	Activation mechanism of the G protein-coupled sweet receptor heterodimer with sweeteners and allosteric agonists.	TAS1R3 TAS1R2	7.07e-06	2	93	2	28228527
Pubmed	Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.	MYH6 MYH7	7.07e-06	2	93	2	2036722
Pubmed	Current Progress in Understanding the Structure and Function of Sweet Taste Receptor.	TAS1R3 TAS1R2	7.07e-06	2	93	2	32607758
Pubmed	Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector.	MYH6 MYH7	7.07e-06	2	93	2	25937279
Pubmed	Taste cell-expressed α-glucosidase enzymes contribute to gustatory responses to disaccharides.	TAS1R3 TAS1R2	7.07e-06	2	93	2	27162343
Pubmed	The role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in humans.	TAS1R3 TAS1R2	7.07e-06	2	93	2	21540445
Pubmed	Loss of the nutrient sensor TAS1R3 leads to reduced bone resorption.	TAS1R3 TAS1R2	7.07e-06	2	93	2	29019082
Pubmed	Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue.	MYH6 MYH7	7.07e-06	2	93	2	15621050
Pubmed	Neural Isolation of the Olfactory Bulbs Severely Impairs Taste-Guided Behavior to Normally Preferred, But Not Avoided, Stimuli.	TAS1R3 TAS1R2	7.07e-06	2	93	2	32152061
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYH7 TBC1D4 MAN2A2 THRA TBK1 ANKRD26 COL14A1 PYGM CDC42BPB	7.69e-06	497	93	9	23414517
Pubmed	Essential role of MESP1-RING1A complex in cardiac differentiation.	MYH6 MYH7 CTCF	8.23e-06	15	93	3	36413948
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZZZ3 THRA CTCF ABCA12 VPS4A FAT3 TBK1 CEP295 WDFY3 PLD1 LBR CUL7 LYAR	8.60e-06	1116	93	13	31753913
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH6 MYH7 MYH7B	1.01e-05	16	93	3	19922871
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	PWP1 USP10 MYADM MAN2A2 CTCF TBK1 UGGT1 HELZ2 CPSF1 COL14A1 PLD1 LBR LYAR CDC42BPB	1.65e-05	1371	93	14	36244648
Pubmed	Sphingomyelin synthase-related protein SMSr is a phosphatidylethanolamine phospholipase C that promotes nonalcoholic fatty liver disease.	SGMS1 SAMD8	2.12e-05	3	93	2	37586586
Pubmed	Endogenous retinoic acid signaling colocalizes with advanced expression of the adult smooth muscle myosin heavy chain isoform during development of the ductus arteriosus.	MYH6 MYH7	2.12e-05	3	93	2	8620598
Pubmed	Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.	MYH6 MYH7	2.12e-05	3	93	2	18362229
Pubmed	Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study.	MYH6 MYH7	2.12e-05	3	93	2	1939265
Pubmed	The downregulation of sweet taste receptor signaling in enteroendocrine L-cells mediates 3-deoxyglucosone-induced attenuation of high glucose-stimulated GLP-1 secretion.	TAS1R3 TAS1R2	2.12e-05	3	93	2	29277113
Pubmed	The receptors for mammalian sweet and umami taste.	TAS1R3 TAS1R2	2.12e-05	3	93	2	14636554
Pubmed	Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.	MYH6 MYH7	2.12e-05	3	93	2	20923879
Pubmed	Three sweet receptor genes are clustered in human chromosome 1.	TAS1R3 TAS1R2	2.12e-05	3	93	2	12856281
Pubmed	Molecular genetic identification of a candidate receptor gene for sweet taste.	TAS1R3 TAS1R2	2.12e-05	3	93	2	11322794
Pubmed	Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro.	MYH6 MYH7	2.12e-05	3	93	2	1694848
Pubmed	Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes.	FAT2 FAT3	2.12e-05	3	93	2	15744052
Pubmed	Amino acid taste receptor regulates insulin secretion in pancreatic β-cell line MIN6 cells.	TAS1R3 TAS1R2	2.12e-05	3	93	2	21470345
Pubmed	Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptors.	TAS1R3 TAS1R2	2.12e-05	3	93	2	24068707
Pubmed	Polymorphic variants in Sweet and Umami taste receptor genes and birthweight.	TAS1R3 TAS1R2	2.12e-05	3	93	2	33654187
Pubmed	REEP2 enhances sweet receptor function by recruitment to lipid rafts.	TAS1R3 TAS1R2	2.12e-05	3	93	2	20943918
Pubmed	Phosphorus Taste Involves T1R2 and T1R3.	TAS1R3 TAS1R2	2.12e-05	3	93	2	28383662
Pubmed	Discordant on/off switching of gene expression in myocytes during cardiac hypertrophy in vivo.	MYH6 MYH7	2.12e-05	3	93	2	18755891
Pubmed	All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.	SGMS1 SAMD8	2.12e-05	3	93	2	25605874
Pubmed	Steviol glycosides enhance pancreatic beta-cell function and taste sensation by potentiation of TRPM5 channel activity.	TAS1R3 TAS1R2	2.12e-05	3	93	2	28361903
Pubmed	An amino-acid taste receptor.	TAS1R3 TAS1R2	2.12e-05	3	93	2	11894099
Pubmed	Identification of a family of animal sphingomyelin synthases.	SGMS1 SAMD8	2.12e-05	3	93	2	14685263
Pubmed	Diacylglycerol kinase ζ interacts with sphingomyelin synthase 1 and sphingomyelin synthase-related protein via different regions.	SGMS1 SAMD8	2.12e-05	3	93	2	37166445
Pubmed	Mutation in myosin heavy chain 6 causes atrial septal defect.	MYH6 MYH7	2.12e-05	3	93	2	15735645
Pubmed	Mammalian sweet taste receptors.	TAS1R3 TAS1R2	2.12e-05	3	93	2	11509186
Pubmed	Taste sensitivity to a mixture of monosodium glutamate and inosine 5'-monophosphate by mice lacking both subunits of the T1R1+T1R3 amino acid receptor.	TAS1R3 TAS1R2	2.12e-05	3	93	2	29443544
Pubmed	Taste receptor T1R3 is an essential molecule for the cellular recognition of the disaccharide trehalose.	TAS1R3 TAS1R2	2.12e-05	3	93	2	12892531
Pubmed	The effects of slow skeletal troponin I expression in the murine myocardium are influenced by development-related shifts in myosin heavy chain isoform.	MYH6 MYH7	2.12e-05	3	93	2	22966157
Pubmed	Conotruncal anomalies in the trisomy 16 mouse: an immunohistochemical analysis with emphasis on the involvement of the neural crest.	MYH6 MYH7	2.12e-05	3	93	2	11066038
Pubmed	Taste information derived from T1R-expressing taste cells in mice.	TAS1R3 TAS1R2	2.12e-05	3	93	2	26912569
Pubmed	The long noncoding RNA Charme supervises cardiomyocyte maturation by controlling cell differentiation programs in the developing heart.	MYH6 MYH7 CUL7	2.75e-05	22	93	3	36877136
Pubmed	Interactome and Proteome Dynamics Uncover Immune Modulatory Associations of the Pathogen Sensing Factor cGAS.	PWP1 USP10 CTCF VPS4A HELZ2 LYAR	3.52e-05	228	93	6	30471916
Pubmed	WD40 repeat and FYVE domain containing 3 is essential for cardiac development.	MYH6 MYH7 WDFY3	4.08e-05	25	93	3	30428088
Pubmed	Altered cardiac phenotype in transgenic mice carrying the delta337 threonine thyroid hormone receptor beta mutant derived from the S family.	MYH6 MYH7	4.23e-05	4	93	2	9927321
Pubmed	Combined cardiomyocyte PKCδ and PKCε gene deletion uncovers their central role in restraining developmental and reactive heart growth.	MYH6 MYH7	4.23e-05	4	93	2	25900833
Pubmed	Changes in expression of nonmuscle myosin heavy chain isoforms during muscle and nonmuscle tissue development.	MYH6 MYH7	4.23e-05	4	93	2	8482409
Pubmed	Two novel/ancient myosins in mammalian skeletal muscles: MYH14/7b and MYH15 are expressed in extraocular muscles and muscle spindles.	MYH7 MYH7B	4.23e-05	4	93	2	19948655
Pubmed	Human receptors for sweet and umami taste.	TAS1R3 TAS1R2	4.23e-05	4	93	2	11917125
Pubmed	Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion.	TAS1R3 TAS1R2	4.23e-05	4	93	2	20876097
Interaction	LZTR1 interactions	MYH6 MYH7 ZZZ3 VPS4A PYGM WDFY3	1.04e-05	111	90	6	int:LZTR1
Cytoband	6p21.1	UBR2 TMEM151B CUL7	5.91e-04	80	93	3	6p21.1
GeneFamily	Myosin heavy chains	MYH6 MYH7 MYH7B	1.96e-05	15	65	3	1098
GeneFamily	Taste 1 receptors	TAS1R3 TAS1R2	3.81e-05	3	65	2	1161
GeneFamily	Glycogen phosphorylases	PYGL PYGM	3.81e-05	3	65	2	437
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDR81 WDFY3	4.51e-04	9	65	2	1230
GeneFamily	Progestin and adipoQ receptor family	ADIPOR1 MMD	6.85e-04	11	65	2	930
GeneFamily	Cadherin related	FAT2 FAT3	1.67e-03	17	65	2	24
GeneFamily	Neuroblastoma breakpoint family	NBPF15 NBPF10	3.07e-03	23	65	2	662
GeneFamily	Cyclins	CCNJL CCNJ	4.53e-03	28	65	2	473
GeneFamily	Tudor domain containing	TDRD9 LBR	7.82e-03	37	65	2	780
GeneFamily	Kelch like\|BTB domain containing	KLHL11 KLHL18	9.99e-03	42	65	2	617
GeneFamily	WD repeat domain containing	PWP1 GTF3C2 WDR81 WDFY3	1.46e-02	262	65	4	362
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 TBC1D4 FAT3 DAPK1 ASTN2 WDFY3	2.23e-06	183	92	6	738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 TBC1D4 FAT3 DAPK1 ASTN2 WDFY3	2.23e-06	183	92	6	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPTLC3 MAL TBC1D4 DAPK1 ASTN2 COL14A1	2.30e-06	184	92	6	d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 TBC1D4 DAPK1 ASTN2 WDFY3 ALPK2	2.44e-06	186	92	6	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MST1R MAL LAMA3 DAPK1 ASTN2 COL14A1	2.52e-06	187	92	6	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MST1R MAL LAMA3 DAPK1 ASTN2 COL14A1	2.52e-06	187	92	6	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MST1R MAL LAMA3 DAPK1 ASTN2 COL14A1	2.52e-06	187	92	6	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 TBC1D4 FAT3 DAPK1 ASTN2 WDFY3	2.68e-06	189	92	6	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 TBC1D4 LAMA3 DAPK1 ASTN2 SIM1	3.12e-06	194	92	6	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRK NTN4 MAL FAT3 DAPK1 SIM1	3.31e-06	196	92	6	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RHPN1 KIAA0825 ANKRD26 CEP295 MELK	1.87e-05	157	92	5	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	Thalamus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf\|Thalamus / BrainAtlas - Mouse McCarroll V32	FAT2 MAL ACTL9 DCST1	2.08e-05	78	92	4	5b45aacaff2a2b98c4ef8e7ac51ad482a69a1d8b
ToppCell	Thalamus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)\|Thalamus / BrainAtlas - Mouse McCarroll V32	FAT2 MAL ACTL9 DCST1	2.08e-05	78	92	4	afed2f358c8a33889931bc5ad8cb24f92323e6f8
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAL MYH7B TAS1R3 FAT3 ITPR2	2.11e-05	161	92	5	f5df8c6a340d5026726804b103e32137f363ca40
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCNJL NTN4 DAPK1 ASTN2 COL14A1	2.30e-05	164	92	5	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 DAPK1 ASTN2 LBR ALPK2	3.14e-05	175	92	5	284fdc7a9d303636a637041846850d19d114861a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 TBC1D4 DAPK1 ASTN2 LBR	3.69e-05	181	92	5	6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
ToppCell	COVID-19-Epithelial-Ionocytes\|Epithelial / Condition, Lineage and Cell class	MAL TBC1D4 ANKRD9 PYGM ITPR2	3.69e-05	181	92	5	4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TBC1D4 FAT3 DAPK1 ASTN2 WDFY3	3.69e-05	181	92	5	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	COVID-19-kidney-CD-IC-B\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTLC3 MAL TBC1D4 ASTN2 SIM1	3.79e-05	182	92	5	ee6a8c356bbbdae55e4ea858337e079491f9f4aa
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SLC9A1 GTF3C2 ANKRD26 E2F6 CRAT	4.31e-05	187	92	5	c8278525b3e1d3f3f4defcaf109cce22dd2e157a
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	SLC9A1 GTF3C2 ANKRD26 E2F6 CRAT	4.54e-05	189	92	5	99b01893da9f9f7c9528afaffad178285211738b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MST1R MAL DAPK1 ASTN2 VWA2	4.54e-05	189	92	5	aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	TBC1D4 DAPK1 ASTN2 WDFY3 SIM1	4.54e-05	189	92	5	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MST1R MAL DAPK1 ASTN2 VWA2	4.54e-05	189	92	5	8977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SPTLC3 SGMS1 DAPK1 ASTN2 COL14A1	4.65e-05	190	92	5	bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SPTLC3 SGMS1 DAPK1 ASTN2 COL14A1	4.65e-05	190	92	5	b6b8964b4910083499681b5fdf554e127b6a4c4e
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 PTPN7 RAB33A LYAR MELK	4.65e-05	190	92	5	b65383e256b04122500b742caeed0b807793851e
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 PTPN7 RAB33A LYAR MELK	4.65e-05	190	92	5	89095d3e023269d89c82e3a73550f869e3f34201
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	MYH6 MYH7 TBC1D4 MYH7B ALPK2	4.65e-05	190	92	5	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SPTLC3 SGMS1 DAPK1 ASTN2 COL14A1	4.77e-05	191	92	5	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	COVID-19-kidney-TAL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTLC3 MAL DAPK1 ASTN2 SIM1	4.77e-05	191	92	5	fe55475ce0666ab5122447a813dc2369e24947b8
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 MYH7 TBC1D4 PYGM ALPK2	4.77e-05	191	92	5	97fb4232417a39801e87725755fd16a57c250209
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 MYH7 TBC1D4 PYGM ALPK2	4.77e-05	191	92	5	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	MYH6 MYH7 TBC1D4 MYH7B ALPK2	4.89e-05	192	92	5	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 MAL LAMA3 DAPK1 ASTN2	5.01e-05	193	92	5	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 MAL LAMA3 DAPK1 ASTN2	5.01e-05	193	92	5	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 TBC1D4 DAPK1 WDFY3 ALPK2	5.14e-05	194	92	5	8ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MYH6 TBC1D4 MYH7B ASTN2 ALPK2	5.14e-05	194	92	5	c3535f7cc0076653c72db582047cff053c322397
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MYH6 MYH7 TBC1D4 MYH7B ALPK2	5.26e-05	195	92	5	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO15B NBPF10 LAMA3 ALDOB ITPR2	5.26e-05	195	92	5	e87b11e3242fdbed2e7f383e6876ec375af32bd4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NTN4 MAL DAPK1 ASTN2 SIM1	5.39e-05	196	92	5	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRK MAL DAPK1 ASTN2 SIM1	5.39e-05	196	92	5	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	severe-Myeloid-Neutrophils_4\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MYADM ADIPOR1 TDRD9 PYGL WDFY3	5.79e-05	199	92	5	50242666def13e5d4149c563ae000d6768f086f7
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTN4 TDRD9 TAS1R2 LAMA3	6.20e-05	103	92	4	c11bb0238e81a42dad5d7687c9d22474129d803d
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYADM TAS1R2 LAMA3 CRAT	8.01e-05	110	92	4	c80d1c3df75648e2c8f6832279c2acca63d76681
Drug	amorphin	PYGL PYGM ALDOB	3.52e-06	8	92	3	CID000122792
Drug	Laevuflex	FRK MYH6 MYH7 SLC9A1 PYGL PYGM ALDOB CRAT	1.46e-05	272	92	8	CID000003426
Drug	paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A	MST1R TBC1D4 ANKRD26 LBR KLHL18 ARHGEF15 RAB33B	1.59e-05	198	92	7	640_UP
Drug	1,6-dichlorosucrose	TAS1R3 TAS1R2	1.62e-05	2	92	2	ctd:C039464
Drug	1-chlorosucrose	TAS1R3 TAS1R2	1.62e-05	2	92	2	ctd:C039463
Drug	1-N-Acetyl-Beta-D-Glucosamine	PYGL PYGM	1.62e-05	2	92	2	DB02320
Drug	neotame	TAS1R3 TAS1R2	1.62e-05	2	92	2	ctd:C404525
Drug	3,5-dimethylphenyl isocyanate	PYGL PYGM	4.83e-05	3	92	2	CID000521488
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGL PYGM	4.83e-05	3	92	2	CID000093111
Drug	adenosine-5'-chloromethylphosphonate	PYGL PYGM	4.83e-05	3	92	2	CID000191554
Drug	trichlorosucrose	TAS1R3 TAS1R2	4.83e-05	3	92	2	ctd:C026285
Drug	hydan	PYGL PYGM	4.83e-05	3	92	2	CID000008360
Drug	EHMF	PYGL PYGM	4.83e-05	3	92	2	CID000033931
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGL PYGM	4.83e-05	3	92	2	CID000147839
Drug	pyridoxal 5'-methylenephosphonate	PYGL PYGM	4.83e-05	3	92	2	CID003082249
Drug	Plp 5'-mpa	PYGL PYGM	4.83e-05	3	92	2	CID003082151
Drug	glucose-1,2-cyclic phosphate	PYGL PYGM	4.83e-05	3	92	2	CID000191723
Drug	3'-FFdUrd	PYGL PYGM	4.83e-05	3	92	2	CID000072260
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGL PYGM	4.83e-05	3	92	2	CID000119518
Drug	AC1L8XK3	PYGL PYGM	4.83e-05	3	92	2	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGL PYGM	4.83e-05	3	92	2	CID000446801
Drug	NSC758405	PYGL PYGM	4.83e-05	3	92	2	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGL PYGM	4.83e-05	3	92	2	CID000151920
Drug	riboflavin tetraacetate	PYGL PYGM	4.83e-05	3	92	2	CID000094186
Drug	pyridoxal phosphoglucose	PYGL PYGM	4.83e-05	3	92	2	CID000196007
Drug	Cyclamates	TAS1R3 TAS1R2	4.83e-05	3	92	2	ctd:D003494
Drug	2,5-dimethyl-3-furanone	PYGL PYGM	4.83e-05	3	92	2	CID000085730
Drug	3,5-dinitrophenol	PYGL PYGM	4.83e-05	3	92	2	CID000011459
Drug	ADP alpha S	PYGL PYGM CRAT	5.90e-05	19	92	3	CID000171069
Drug	galocitabine	PYGL PYGM	9.64e-05	4	92	2	CID000065950
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGL PYGM	9.64e-05	4	92	2	CID000189134
Drug	AC1LAMW2	PYGL PYGM	9.64e-05	4	92	2	CID000491364
Drug	FdUrd-C8	PYGL PYGM	9.64e-05	4	92	2	CID000094262
Drug	Mem-CC	PYGL PYGM	9.64e-05	4	92	2	CID003081269
Drug	5-deoxyribose-1-phosphate	PYGL PYGM	9.64e-05	4	92	2	CID000135786
Drug	ingliforib	PYGL PYGM	9.64e-05	4	92	2	CID006451325
Drug	uric acid riboside	PYGL PYGM	9.64e-05	4	92	2	CID000164933
Drug	pseudo-dl-glucose	PYGL PYGM	9.64e-05	4	92	2	CID000125259
Drug	4-carb-oxy-butano-ate	ESD MMD	9.64e-05	4	92	2	CID000073917
Drug	BCIp4A	PYGL PYGM	9.64e-05	4	92	2	CID000192417
Drug	pyridoxal diphosphate	PYGL PYGM	9.64e-05	4	92	2	CID000125696
Drug	3'-chloromethotrexate	PYGL PYGM	9.64e-05	4	92	2	CID000097703
Drug	dihydrolipoamide	LIPT1 TBK1 PYGL PYGM PLD1	1.23e-04	119	92	5	CID000000663
Drug	Iodixanol [92339-11-2]; Up 200; 2.6uM; MCF7; HT_HG-U133A	MST1R THRA PEAK1 CUL7 ENTPD4 ITPR2	1.50e-04	197	92	6	3362_UP
Drug	Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A	MYH7 RAB33A ANKRD26 PLD1 PEAK1 CUL7	1.54e-04	198	92	6	5996_UP
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A	SPTLC3 ANKRD26 WDFY3 CUL7 ENTPD4 ITPR2	1.54e-04	198	92	6	3756_DN
Drug	heptulose-2-P	PYGL PYGM	1.60e-04	5	92	2	CID000124823
Drug	m-anisidine	PYGL PYGM	1.60e-04	5	92	2	CID000010824
Drug	6-FPLP	PYGL PYGM	1.60e-04	5	92	2	CID000146246
Drug	gluconohydroximo-1,5-lactone	PYGL PYGM	1.60e-04	5	92	2	CID009576855
Drug	2-hydroxypropylphosphonate	PYGL PYGM	1.60e-04	5	92	2	CID000441028
Drug	DHPBU	PYGL PYGM	1.60e-04	5	92	2	CID000125914
Drug	6-FDPL	PYGL PYGM	1.60e-04	5	92	2	CID000129578
Drug	dimethylglutarate	ESD MMD	1.60e-04	5	92	2	CID000014242
Drug	5'-isobutylthioinosine	PYGL PYGM	1.60e-04	5	92	2	CID003080910
Drug	3'-O-methylpyridoxal 5'-phosphate	PYGL PYGM	1.60e-04	5	92	2	CID003082179
Drug	GlcMan	PYGL PYGM	1.60e-04	5	92	2	CID000152120
Drug	U66985	PYGL PYGM	1.60e-04	5	92	2	CID000127224
Drug	indirubin-5-sulphonate	PYGL PYGM	1.60e-04	5	92	2	CID005288641
Drug	AC1O3M08	PYGL PYGM	1.60e-04	5	92	2	CID006331955
Drug	AC1LCUXJ	PYGL PYGM	1.60e-04	5	92	2	CID000656425
Drug	6-amino-5-bromouracil	PYGL PYGM	1.60e-04	5	92	2	CID000080578
Drug	etafenone	PYGL PYGM	1.60e-04	5	92	2	CID000003275
Drug	ddEtUrd	PYGL PYGM	1.60e-04	5	92	2	CID000451452
Drug	5-trifluoromethyl-2'-deoxycytidine	PYGL PYGM	1.60e-04	5	92	2	CID000125618
Drug	diHPA	MYH6 THRA	1.60e-04	5	92	2	CID000151819
Drug	1-o-phosphonohex-2-ulose	PYGL PYGM ALDOB	2.16e-04	29	92	3	CID000000481
Drug	CV-araU	PYGL PYGM	2.40e-04	6	92	2	CID006441877
Drug	2-thiothymidine	PYGL PYGM	2.40e-04	6	92	2	CID003005944
Drug	GC 1 compound	MYH6 MYH7	2.40e-04	6	92	2	ctd:C413355
Drug	Carbocyclic Bvdc	PYGL PYGM	2.40e-04	6	92	2	CID006438602
Drug	DNPP	PYGL PYGM	2.40e-04	6	92	2	CID000067056
Drug	5-chloro-indole-2-carboxylic acid	PYGL PYGM	2.40e-04	6	92	2	CID000082693
Drug	2,2-dimethyl-3-hydroxybutyric acid	PYGL PYGM	2.40e-04	6	92	2	CID000152984
Drug	lactisole	TAS1R3 TAS1R2	2.40e-04	6	92	2	ctd:C495512
Drug	EdUMP	PYGL PYGM	2.40e-04	6	92	2	CID003085112
Drug	4-hydroxyacetophenone	PYGL PYGM	2.40e-04	6	92	2	ctd:C031335
Drug	5'-deoxy-5'-chloroformycin	PYGL PYGM	2.40e-04	6	92	2	CID000126430
Drug	NSC-97433	PYGL PYGM	2.40e-04	6	92	2	CID000001803
Drug	5-n-propylthioadenosine	PYGL PYGM	2.40e-04	6	92	2	CID000656428
Drug	AzddCyd	PYGL PYGM	2.40e-04	6	92	2	CID000451374
Drug	5-Ffdru	PYGL PYGM	2.40e-04	6	92	2	CID000065561
Drug	AR-L57	PYGL PYGM	2.40e-04	6	92	2	CID000156890
Drug	tegaserod	THRA HTR4	2.40e-04	6	92	2	ctd:C105050
Drug	Carbocyclic Ivdu	PYGL PYGM	2.40e-04	6	92	2	CID006439191
Drug	2,5-anhydro-D-mannitol	PYGL PYGM CRAT	2.64e-04	31	92	3	CID000001494
Drug	AC1L9I7L	ESD PYGL PYGM MMD	2.98e-04	79	92	4	CID000445564
Drug	alpha-(fluoromethyl)dehydroornithine	PYGL PYGM	3.35e-04	7	92	2	CID006439607
Drug	6-fluoropyridoxal	PYGL PYGM	3.35e-04	7	92	2	CID003080803
Drug	2',3'-dideoxy-3'-fluorocytidine	PYGL PYGM	3.35e-04	7	92	2	CID000356019
Drug	heptenitol	PYGL PYGM	3.35e-04	7	92	2	CID000188267
Drug	AC1L3372	PYGL PYGM	3.35e-04	7	92	2	CID000108025
Drug	1 Gpt	PYGL PYGM	3.35e-04	7	92	2	CID000101247
Drug	formycins	PYGL PYGM	3.35e-04	7	92	2	CID000512867
Drug	Promonta	PYGL PYGM	3.35e-04	7	92	2	CID000108494
Drug	5'-methylthioinosine	PYGL PYGM	3.35e-04	7	92	2	CID000161214
Drug	hydantocidin	PYGL PYGM	3.35e-04	7	92	2	CID000125429
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH6 MYH7 MYH7B	3.24e-06	10	90	3	DOID:0110454 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH6 MYH7 MYH7B	3.24e-06	10	90	3	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH6 MYH7 MYH7B	3.24e-06	10	90	3	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH6 MYH7 MYH7B	3.24e-06	10	90	3	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH6 MYH7 MYH7B	3.24e-06	10	90	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH6 MYH7 MYH7B	3.24e-06	10	90	3	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH6 MYH7 MYH7B	3.24e-06	10	90	3	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH6 MYH7 MYH7B	3.24e-06	10	90	3	DOID:0111596 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH6 MYH7 MYH7B	5.92e-06	12	90	3	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH6 MYH7 MYH7B	5.92e-06	12	90	3	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH6 MYH7 MYH7B	7.68e-06	13	90	3	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH6 MYH7 MYH7B	1.22e-05	15	90	3	DOID:0050646 (implicated_via_orthology)
Disease	Caveolinopathy	MYH6 MYH7	5.50e-05	4	90	2	cv:C5679790
Disease	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH6 MYH7	5.50e-05	4	90	2	192600
Disease	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	MYH6 MYH7	5.50e-05	4	90	2	C3495498
Disease	Hypertrophic cardiomyopathy 1	MYH6 MYH7	5.50e-05	4	90	2	cv:C3495498
Disease	Hypertrophic obstructive cardiomyopathy	MYH6 MYH7 SLC9A1	6.01e-05	25	90	3	C4551472
Disease	Idiopathic hypertrophic subaortic stenosis	MYH6 MYH7	1.91e-04	7	90	2	C0700053
Disease	Obstructive asymmetric septal hypertrophy	MYH6 MYH7	1.91e-04	7	90	2	C0597124
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH6 MYH7	3.27e-04	9	90	2	C0949658
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 MYH7	4.07e-04	10	90	2	cv:C5675009
Disease	myopathy (implicated_via_orthology)	MYH6 MYH7 MYH7B	4.30e-04	48	90	3	DOID:423 (implicated_via_orthology)
Disease	factor VII activating protease measurement	USP10 HELZ2 MELK	6.42e-04	55	90	3	EFO_0009368
Disease	Hypertrophic Cardiomyopathy	MYH6 MYH7 SLC9A1	7.13e-04	57	90	3	C0007194
Disease	trimethylamine-N-oxide measurement	TAS1R2 ITPR2	8.17e-04	14	90	2	EFO_0010541
Disease	Left ventricular noncompaction	MYH7 MYH7B	8.17e-04	14	90	2	C1960469
Disease	cardiomyopathy (implicated_via_orthology)	MYH6 MYH7 MYH7B	1.35e-03	71	90	3	DOID:0050700 (implicated_via_orthology)
Disease	hypothyroidism (biomarker_via_orthology)	MYH6 MYH7 SLC9A1	1.90e-03	80	90	3	DOID:1459 (biomarker_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH6 MYH7 MYH7B	1.90e-03	80	90	3	DOID:12930 (implicated_via_orthology)
Disease	hypertrophic cardiomyopathy (is_implicated_in)	MYH7 MYH7B	2.04e-03	22	90	2	DOID:11984 (is_implicated_in)
Disease	Primary familial hypertrophic cardiomyopathy	MYH6 MYH7	2.04e-03	22	90	2	cv:C0949658
Disease	Limb-girdle muscular dystrophy	MYH6 MYH7	2.85e-03	26	90	2	cv:C0686353
Disease	urate measurement, bone density	SPTLC3 HELZ2 PEAK1 SIM1 USH2A ENTPD4 ITPR2	2.88e-03	619	90	7	EFO_0003923, EFO_0004531

Protein segments in the cluster

Peptide	Gene	Start	Entry
QLTTDFVHHYIVANY	BHLHB9	431	Q6PI77
FVHHYIVANYFSELF	BHLHB9	436	Q6PI77
SYYFIATFITDHIRH	ESD	261	P10768
GVYYLHSLQIAHFDL	DAPK1	126	P53355
YCDAVFHERYALIQH	CTCF	471	P49711
YEFFENQYIHVLHLS	ALPK2	61	Q86TB3
AAVYKALNDHHVYLE	ALDOB	211	P05062
VTVEEHLYFYARVHG	ABCA12	2346	Q86UK0
VENIKHHYCYVASDF	ACTL9	251	Q8TC94
EYAHYFLEVTLQDHI	CCNJL	231	Q8IV13
TAAHFIEYYLSEAVH	CCNJ	146	Q5T5M9
FHAEIYFDHDLQSYV	AGGF1	456	Q8N302
VHNYQFFELDVYHSD	CRAT	206	P43155
VHAHAVGPFSVYVDY	ARHGEF15	496	O94989
LADVHGNTALHYAVY	ANKRD26	141	Q9UPS8
EELLSFIQHYGSHYI	ASTN2	891	O75129
SMVEHYYRNVHAVVF	RAB33A	101	Q14088
QHYYRNVHAVVFVYD	RAB33B	101	Q9H082
ANQDDYISFRHHVYK	IMP4	221	Q96G21
TAEQYQFLHHTLALY	PTPN7	336	P35236
YYANHTAQIEIVRHD	ITPR2	2141	Q14571
TSLFQGVEFHYVYSH	LBR	311	Q14739
HFSLIHYAGIVDYNI	MYH7	576	P12883
IVSAVAYVHSQGYAH	MELK	116	Q14680
HVLVVAAAFVHFYGV	ADIPOR1	341	Q96A54
KFYHDFHSEIFQYTV	KIAA0100	1081	Q14667
RYVFVIHFYQAAHPT	LAMA3	1126	Q16787
NLHTYLSTAVYVFQH	KIAA0825	546	Q8IV33
HFVAHYLRAQQEEYA	MYO19	441	Q96H55
VATEYAAYHQIDNHI	LIPT1	231	Q9Y234
HYLHQANYSIIDDAT	KIAA1109	2111	Q2LD37
TAHYVAYHVESKVYA	CPSF1	1021	Q10570
AHFEVVHYAGVVPYS	MYH7B	621	A7E2Y1
ETCQTYHFHVVAYDH	FAT2	2866	Q9NYQ8
YHFHVVAYDHGQTIQ	FAT2	2871	Q9NYQ8
YYHSLAVRQSLAVHF	PEAK1	1371	Q9H792
SGLEIATTFEHYYQH	CUL7	1256	Q14999
FVYATLQTAHYHRDA	CES4A	426	Q5XG92
AYVADLVHSAHLVFV	MYADM	306	Q96S97
ITALHYAFQDENHLY	CDC42BPB	136	Q9Y5S2
CHVTHVLPNVYYEFF	OOSP1	61	A8MZH6
YEHAANCYTHAFLIV	MMD	26	Q15546
FTVRHYAGTVTYQVH	MYO15B	146	Q96JP2
QRHGHYFVALFDYQA	FRK	41	P42685
HLDGHAVAVTESYVY	KLHL11	396	Q9NVR0
YDAANSFIHQHFVEV	KLHL18	156	O94889
AYVTYQDIHSIQAFH	E2F6	181	O75461
LSYQDAAFTYHHIQE	DOCK2	896	Q92608
YSIFDTIRHHSFLQY	DCST1	481	Q5T197
TEYQIAVFAIYAHTA	COL14A1	416	Q05707
FHFTHSIYNATVYEN	FAT3	41	Q8TDW7
AYYRIYVTAKEHAHQ	HTR4	211	Q13639
VHDHQAYAHYLLATF	ANKRD9	81	Q96BM1
GFTYRHYHENIAAVV	MAL	116	P21145
HYHENIAAVVFSYIA	MAL	121	P21145
FSEVVAYYEHIHQAV	MAN2A2	841	P49641
VLAQYYTVTDEHHRS	LYAR	336	Q9NX58
VLHDTYYVVAHFHYV	MT-CO1	366	P00395
NSAADIYIREYFHSH	HELZ2	576	Q9BYK8
NHAVLSYAVEEEHAY	CEP295	1926	Q9C0D2
RFHFHGQYYTTETAV	USH2A	486	O75445
VLAEYRTAYAHYHVE	TMEM151B	316	Q8IW70
AHEHYSIDVFIAFYI	SAMD8	341	Q96LT4
FSVVHSVLHVDVYQY	TDRD9	1051	Q8NDG6
QHFTHYAIYDFIVKG	NTN4	246	Q9HB63
QHYRSVFYSFEEQHI	NBPF10	3751	Q6P3W6
QHYRSVFYSFEEEHI	NBPF15	626	Q8N660
YVHVIENSRHYIYIE	PLD1	766	Q13393
VHQTEHVYRVYVATF	ENTPD4	311	Q9Y227
TAHQPYHSHFVQEYE	SIM1	141	P81133
YHSHFVQEYEIERSF	SIM1	146	P81133
LVDYLRVHSHSAVYA	SPTLC3	386	Q9NUV7
AHFSLIHYAGTVDYN	MYH6	576	P13533
VKAEYFRSLAHYHVA	RHPN1	346	Q8TCX5
LSYVHVTVDTYSHFI	ERVK-25	661	P63136
YVNVYGTHVLVSAAH	TGDS	116	O95455
VHVYNQEEDSFYVHH	PWP1	166	Q13610
NHHQTFSVYAAVYSV	TAS1R3	386	Q7RTX0
FSVYAAVYSVAQALH	TAS1R3	391	Q7RTX0
FHHLFYEGQVDIYNI	WDFY3	2931	Q8IZQ1
DYYFALAHTVRDHLV	PYGM	51	P11217
VQVQHLSYNYSAFHF	SERINC4	416	A6NH21
ATVFHAYYLSAVANA	TERB2	61	Q8NHR7
IHVAAYADLRYHQDV	VWA2	686	Q5GFL6
YYSSFIIHQRVHTGE	ZNF211	296	Q13398
VVLYHLFEEFANYEH	SLC9A1	271	P19634
HDHYTVDVVVAYYIT	SGMS1	326	Q86VZ5
HNSHDLTYFAYLIKA	TBC1D4	131	O60343
YSVYSAVYAVAHALH	TAS1R2	386	Q8TE23
TYRLFAVVYHHGNSA	USP10	731	Q14694
TYTETVNHHYLLFQD	GTF3C2	786	Q8WUA4
SQEAYLLAFEHYVNH	THRA	341	P10827
VFLSHYYLHVRADLQ	PIEZO1	1301	Q92508
HVVQFYHYFEDKENI	PLK2	141	Q9NYY3
ATDLTREVYQHLAHY	UBR2	31	Q8IWV8
DYYFALAHTVRDHLV	PYGL	51	P06737
DVYYFESDHVALKHN	ZZZ3	486	Q8IYH5
SIEYVHSFHTGAFVY	MST1R	246	Q04912
LYVVHPYVQFSLHDV	WDR81	231	Q562E7
EVDDYHAFQTLTHIY	UGGT1	561	Q9NYU2
IHSYNTATIFHELVY	TBK1	326	Q9UHD2
VEYFLHAIKYEAHSD	VPS4A	36	Q9UN37